In efforts to help limit the spread of SARS-CoV2 and minimize the risk of COVID-19 to patients, providers and staff, many governing bodies are categorizing essential and non-essential clinical guidelines to help with prioritization and planning. While maintaining and adjusting safety procedures that work best for each institution, state agency, and community is paramount,
neonatal cytomegalovirus (CMV) screening, evaluation and treatment should continue to be performed per routine institutional protocols and considered essential patient care.